These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 6548545
1. Molecular structures of metabolites and analogues of diethylstilbestrol and their relationship to receptor binding and biological activity. Duax WL, Swenson DC, Strong PD, Korach KS, McLachlan J, Metzler M. Mol Pharmacol; 1984 Nov; 26(3):520-5. PubMed ID: 6548545 [Abstract] [Full Text] [Related]
2. Estrogen receptor stereochemistry: ligand binding orientation and influence on biological activity. Chae K, Gibson MK, Korach KS. Mol Pharmacol; 1991 Nov; 40(5):806-11. PubMed ID: 1944245 [Abstract] [Full Text] [Related]
3. Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens. Labaree DC, Zhang JX, Harris HA, O'Connor C, Reynolds TY, Hochberg RB. J Med Chem; 2003 May 08; 46(10):1886-904. PubMed ID: 12723952 [Abstract] [Full Text] [Related]
4. Diethylstilbestrol metabolites and analogs: differential ligand effects on estrogen receptor interactions with nuclear matrix sites. Metzger DA, Curtis S, Korach KS. Endocrinology; 1991 Apr 08; 128(4):1785-91. PubMed ID: 2004602 [Abstract] [Full Text] [Related]
5. Molecular conformation, receptor binding, and hormone action of natural and synthetic estrogens and antiestrogens. Duax WL, Griffin JF, Weeks CM, Korach KS. Environ Health Perspect; 1985 Sep 08; 61():111-21. PubMed ID: 3905370 [Abstract] [Full Text] [Related]
7. Simulation of the different biological activities of diethylstilbestrol (DES) on estrogen receptor alpha and estrogen-related receptor gamma. Nam K, Marshall P, Wolf RM, Cornell W. Biopolymers; 2003 Jan 08; 68(1):130-8. PubMed ID: 12579585 [Abstract] [Full Text] [Related]
8. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method. van Lipzig MM, ter Laak AM, Jongejan A, Vermeulen NP, Wamelink M, Geerke D, Meerman JH. J Med Chem; 2004 Feb 12; 47(4):1018-30. PubMed ID: 14761204 [Abstract] [Full Text] [Related]
9. Estrogenic activity in vivo and in vitro of some diethylstilbestrol metabolites and analogs. Korach KS, Metzler M, McLachlan JA. Proc Natl Acad Sci U S A; 1978 Jan 12; 75(1):468-71. PubMed ID: 272664 [Abstract] [Full Text] [Related]
10. Steroid receptor forms and their interaction with cytoplasmic modulators. Sato B, Nishizawa Y, Maeda Y, Noma K, Honma T, Matsumoto K. J Steroid Biochem; 1983 Jul 12; 19(1A):315-21. PubMed ID: 6887866 [Abstract] [Full Text] [Related]
11. Diethylstilbestrol metabolites and analogs. Stereochemical probes for the estrogen receptor binding site. Korach KS, Chae K, Levy LA, Duax WL, Sarver PJ. J Biol Chem; 1989 Apr 05; 264(10):5642-7. PubMed ID: 2925625 [Abstract] [Full Text] [Related]
12. Multiple estrogen binding sites in the uterus: stereochemistry of receptor and non-receptor binding of diethylstilbestrol and its metabolites. Chae K, Johnston SH, Korach KS. J Steroid Biochem Mol Biol; 1991 Jan 05; 38(1):35-42. PubMed ID: 1997122 [Abstract] [Full Text] [Related]
13. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties. Lobaccaro C, Pons JF, Duchesne MJ, Auzou G, Pons M, Nique F, Teutsch G, Borgna JL. J Med Chem; 1997 Jul 04; 40(14):2217-27. PubMed ID: 9216841 [Abstract] [Full Text] [Related]
14. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships. Connor K, Ramamoorthy K, Moore M, Mustain M, Chen I, Safe S, Zacharewski T, Gillesby B, Joyeux A, Balaguer P. Toxicol Appl Pharmacol; 1997 Jul 04; 145(1):111-23. PubMed ID: 9221830 [Abstract] [Full Text] [Related]
15. Induction of the estrogen specific mitogenic response of MCF-7 cells by selected analogues of estradiol-17 beta: a 3D QSAR study. Wiese TE, Polin LA, Palomino E, Brooks SC. J Med Chem; 1997 Oct 24; 40(22):3659-69. PubMed ID: 9357533 [Abstract] [Full Text] [Related]
16. Binding characteristics of dialkyl phthalates for the estrogen receptor. Nakai M, Tabira Y, Asai D, Yakabe Y, Shimyozu T, Noguchi M, Takatsuki M, Shimohigashi Y. Biochem Biophys Res Commun; 1999 Jan 19; 254(2):311-4. PubMed ID: 9918834 [Abstract] [Full Text] [Related]
17. Three-dimensional quantitative structure-activity relationship study of nonsteroidal estrogen receptor ligands using the comparative molecular field analysis/cross-validated r2-guided region selection approach. Sadler BR, Cho SJ, Ishaq KS, Chae K, Korach KS. J Med Chem; 1998 Jun 18; 41(13):2261-7. PubMed ID: 9632359 [Abstract] [Full Text] [Related]
18. Synthesis and evaluation of 17alpha-20E-21-(4-substituted phenyl)-19-norpregna-1,3,5(10),20-tetraene-3,17beta-diols as probes for the estrogen receptor alpha hormone binding domain. Hanson RN, Lee CY, Friel CJ, Dilis R, Hughes A, DeSombre ER. J Med Chem; 2003 Jul 03; 46(14):2865-76. PubMed ID: 12825929 [Abstract] [Full Text] [Related]
19. Three-dimensional model of nonsteroidal estrogen receptor ligand binding/electron topological method. Guzel Y, Sivritas K. Arzneimittelforschung; 2004 Jul 03; 54(6):348-54. PubMed ID: 15281621 [Abstract] [Full Text] [Related]
20. Novel estrogen receptor ligands based on an anthranylaldoxime structure: role of the phenol-type pseudocycle in the binding process. Minutolo F, Antonello M, Bertini S, Ortore G, Placanica G, Rapposelli S, Sheng S, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA, Macchia M. J Med Chem; 2003 Sep 11; 46(19):4032-42. PubMed ID: 12954056 [Abstract] [Full Text] [Related] Page: [Next] [New Search]